+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Spasticity Treatment Market 2019-2023 - Product Image

Global Spasticity Treatment Market 2019-2023

  • ID: 4760034
  • Report
  • March 2019
  • Region: Global
  • 112 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Allergan
  • F. Hoffmann-La Roche Ltd
  • Ipsen Pharma
  • Pfizer Inc.
  • UCB S.A.
  • MORE
The growing popularity of physical therapy is one of the key factors driving the growth of global spasticity treatment market. Patients are increasingly adopting this physical therapy treatment because it has minimal side effects. Several advantages of physiotherapy are encouraging various hospitals to invest in a physiotherapy center. Similarly, many healthcare authorities and hospitals of several countries are working on opening physical therapy centers in hospitals for the treatment of many chronic conditions such as spasticity. This will lead to increase patient adherence and is expected to drive the growth of the global spasticity treatment market during the forecast period. The analysts have predicted that the spasticity treatment market will register a CAGR of close to 4% by 2023.

Market Overview

Availability of advanced technologies for drug delivery

One of the growth drivers of the global spasticity treatment market is the availability of advanced technologies for drug delivery. The growing novel drug delivery systems help in delivering the drugs to the target site for improving treatment efficacy, which will drive the market growth during the forecast period.

A long time is taken to gain benefits in physical therapy

One of the challenges in the growth of the global spasticity treatment market is the long time taken to gain benefits in physical therapy. Several limitations such as long duration of physical therapy coupled with its high treatment costs and differences in service delivery create a negative impact on the growth of the market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the spasticity treatment market during 2019-2023, view this report.

Competitive Landscape

The market appears to be moderately fragmented and with the presence of several vendors. The vendors in the market are focusing on developing neurostimulation devices to treat spasticity in combination with medications available because sometimes physical therapies are compounded by the adverse side-effects. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan
  • F. Hoffmann-La Roche Ltd
  • Ipsen Pharma
  • Pfizer Inc.
  • UCB S.A.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY TYPE
  • Market segmentation by type
  • Comparison by type
  • Drug therapy - Market size and forecast 2018-2023
  • Physical therapy - Market size and forecast 2018-2023
  • Market opportunity by type
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Allergan
  • F. Hoffmann-La Roche Ltd
  • Ipsen Pharma
  • Pfizer Inc.
  • UCB S.A.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Type - Market share 2018-2023 (%)
Exhibit 18: Comparison by type
Exhibit 19: Drug therapy - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Drug therapy - Year-over-year growth 2019-2023 (%)
Exhibit 21: Physical therapy - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Physical therapy - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by type
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
Exhibit 29: Top 3 countries in North America
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in Europe
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Asia
Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in ROW
Exhibit 39: Market opportunity
Exhibit 40: Chronic conditions and spasticity: Overview
Exhibit 41: TBI-related hospitalizations by age group and injury mechanism in US 2006-2010
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Neurostimulation devices by companies
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Allergan - Vendor overview
Exhibit 50: Allergan - Business segments
Exhibit 51: Allergan - Organizational developments
Exhibit 52: Allergan - Geographic focus
Exhibit 53: Allergan - Key offerings
Exhibit 54: Allergan - Key customers
Exhibit 55: F. Hoffmann-La Roche Ltd - Vendor overview
Exhibit 56: F. Hoffmann-La Roche Ltd - Business segments
Exhibit 57: F. Hoffmann-La Roche Ltd - Organizational developments
Exhibit 58: F. Hoffmann-La Roche Ltd - Geographic focus
Exhibit 59: F. Hoffmann-La Roche Ltd - Segment focus
Exhibit 60: F. Hoffmann-La Roche Ltd - Key offerings
Exhibit 61: F. Hoffmann-La Roche Ltd - Key customers
Exhibit 62: Ipsen Pharma - Vendor overview
Exhibit 63: Ipsen Pharma - Business segments
Exhibit 64: Ipsen Pharma - Organizational developments
Exhibit 65: Ipsen Pharma - Geographic focus
Exhibit 66: Ipsen Pharma - Segment focus
Exhibit 67: Ipsen Pharma - Key offerings
Exhibit 68: Ipsen Pharma - Key customers
Exhibit 69: Pfizer Inc. - Vendor overview
Exhibit 70: Pfizer Inc. - Business segments
Exhibit 71: Pfizer Inc. - Organizational developments
Exhibit 72: Pfizer Inc. - Geographic focus
Exhibit 73: Pfizer Inc. - Segment focus
Exhibit 74: Pfizer Inc. - Key offerings
Exhibit 75: Pfizer Inc. - Key customers
Exhibit 76: UCB S.A. - Vendor overview
Exhibit 77: UCB S.A. - Business segments
Exhibit 78: UCB S.A. - Organizational developments
Exhibit 79: UCB S.A. - Geographic focus
Exhibit 80: UCB S.A. - Key offerings
Exhibit 81: UCB S.A. - Key customers
Exhibit 82: Validation techniques employed for market sizing
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Allergan
  • F. Hoffmann-La Roche Ltd
  • Ipsen Pharma
  • Pfizer Inc.
  • UCB S.A.
  • MORE
Global Spasticity treatment Market 2019-2023

The analyst recognizes the following companies as the key players in the global spasticity treatment market: Allergan, F. Hoffmann-La Roche Ltd, Ipsen Pharma, Pfizer Inc., and UCB S.A.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the advent of neurostimulation devices.”

According to the report, one of the major drivers for this market is the growing popularity of physical therapy.

Further, the report states that one of the major factors hindering the growth of this market is the weak pipeline for spasticity treatment drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Allergan
  • F. Hoffmann-La Roche Ltd
  • Ipsen Pharma
  • Pfizer Inc.
  • UCB S.A.
Note: Product cover images may vary from those shown
Adroll
adroll